The effect of GM-CSF (see Figure 3D,G) suggested the possibility that the JAK2V617F mutation alone might not be sufficient to induce CD24 expression and reduce efferocytosis in MPN neutrophils. Here, CSF2 is linked to myeloproliferative neoplasm.